Adults:  1-3 weeks; the endpoint is the resolution of disease [Dermatophyte (tinea) infections - UpToDate].  

Pediatrics: 2-3 weeks; continue application for at least 14 days beyond clinical resolution to reduce likelihood of relapse [Antifungal agents for common outpatient paediatric infections | Canadian Paediatric Society (cps.ca)].